NIBIB and CDRH Sign Interagency Agreement Establishing Joint Laboratory
Bethesda, Maryland The National Institute of Biomedical Imaging and Bioengineering (NIBIB) at the National Institutes of Health and the Center for Devices and Radiological Health (CDRH) at the Food and Drug Administration signed an interagency agreement recently establishing a joint Laboratory for the Assessment of Medical Imaging Systems (LAMIS). The purpose of this joint effort is to assess and optimize high-resolution, high-dimensional medical imaging systems.
The goals of LAMIS are to develop evaluation methodology based on advanced statistical tools, determine fundamental limitations imposed on imaging systems, characterize and optimize medical imaging systems and components, build consensus, provide advanced image evaluation methods, and develop an environment conducive to rapid deployment of improved imaging systems and components to the patient community. In addition, optimal hardware designs and approaches for image reconstruction and extracting features will be pursued.
"The joint agreement with CDRH is an exciting opportunity for the NIBIB, and will provide us with another avenue for exploring innovative and high-quality technologies and interdisciplinary research that will lead to improved healthcare. The CDRH medical imaging program is stellar, and we are proud to collaborate with an organization of this caliber," said NIBIB Director Roderic I. Pettigrew, Ph.D., M.D.
"CDRH welcomes this opportunity to collaborate with NIBIB," said CDRH Director David W. Feigal, M.D., M.P.H. "Not only will this new agreement strengthen the imaging programs of both organizations, but it will also benefit the public by leading to the earlier availability of safe, effective medical imaging technologies."
To carry out the mission of the new laboratory, a multidisciplinary team of clinicians, scientists, and mathematicians/statisticians will be assembled. The team will work with visiting scientists and trainees from graduate and medical students to senior researchers and clinicians. Visitors to the laboratory will apply assessment methods developed by the group to their own problems, and carry with them the principles and tools for longer-term use when they leave.
The NIBIB and the CDRH have a mutual interest in the assessment of the performance of medical imaging systems. The mission of the NIBIB is to improve health by leading the development and application of emerging and breakthrough biomedical technologies based in the physical and engineering sciences, including the translation and assessment of technological capabilities in biomedical imaging. The CDRH, as a regulatory arm of the FDA, promotes and protects the health of the public by ensuring the safety and effectiveness of medical devices. The interagency agreement establishing LAMIS will benefit both organizations.
Co-directors of the program are Peter Kirchner, M.D., Acting Director of the Intramural Science Program, NIBIB; and David Brown, Ph.D., Director of the Division of Electronics and Computer Science, Office of Science and Technology, CDRH.